drugset / Trial / NCT03348527
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer
RandomizedParallel-groupSingle-blindTreatment
Summary
A Single Blind, Two-Stage Dose Finding Study to Evaluate the Safety, Tolerability and Efficacy of a Single Liproca® Depot Injection into the Prostate in Patients with Localized Prostate Cancer,Assigned to Active Surveillance who are at High Risk for Disease Progression (followed by an Open Label Extension with a Repeat Injection (Optional))
Timeline
- Start
- 2017-05-12
- Primary completion
- 2020-10-30
- Completion
- 2020-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HYDROXYFLUTAMIDE | Small molecule | 16 ml | Other |
| Subject | HYDROXYFLUTAMIDE | Small molecule | 20 ml | Other |
| Subject | HYDROXYFLUTAMIDE | Small molecule | 35 % | Other |
| Subject | HYDROXYFLUTAMIDE | Small molecule | 45 % | Other |